Samuel D. Wright

38.0k total citations · 8 hit papers
219 papers, 29.2k citations indexed

About

Samuel D. Wright is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Samuel D. Wright has authored 219 papers receiving a total of 29.2k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Immunology, 64 papers in Molecular Biology and 63 papers in Surgery. Recurrent topics in Samuel D. Wright's work include Immune Response and Inflammation (45 papers), Lipoproteins and Cardiovascular Health (34 papers) and Cell Adhesion Molecules Research (33 papers). Samuel D. Wright is often cited by papers focused on Immune Response and Inflammation (45 papers), Lipoproteins and Cardiovascular Health (34 papers) and Cell Adhesion Molecules Research (33 papers). Samuel D. Wright collaborates with scholars based in United States, Australia and Switzerland. Samuel D. Wright's co-authors include Peter S. Tobias, Richard J. Ulevitch, Robert Ramos, John C. Mathison, Samuel C. Silverstein, Eric Hailman, Tian‐Quan Cai, P A Detmers, Terje Espevik and M T Jong and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Samuel D. Wright

217 papers receiving 28.3k citations

Hit Papers

CD14, a Receptor for Complexes of Lipopolysaccharide (LPS... 1982 2026 1996 2011 1990 2010 1990 1994 1992 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
    1990 3.4k citations Samuel D. Wright, Robert Ramos et al. profile →
  2. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
    2010 3.1k citations Samuel D. Wright et al. profile →
  3. Structure and Function of Lipopolysaccharide Binding Protein
    1990 1.4k citations Samuel D. Wright et al. profile →
  4. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.
    1994 632 citations Samuel D. Wright et al. The Journal of Experimental Medicine profile →
  5. Soluble CD14 participates in the response of cells to lipopolysaccharide.
    1992 591 citations Samuel D. Wright et al. The Journal of Experimental Medicine profile →
  6. Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies.
    1983 591 citations Samuel D. Wright et al. profile →
  7. (d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G
    2005 529 citations Andrew K.P. Taggart, Xiaodong Gan et al. Journal of Biological Chemistry profile →
  8. Human neutrophil Fc gamma receptor distribution and structure.
    1982 510 citations Samuel D. Wright et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel D. Wright United States 86 13.9k 9.6k 4.5k 4.3k 3.9k 219 29.2k
Niels Borregaard Denmark 88 13.4k 1.0× 10.2k 1.1× 1.5k 0.3× 2.8k 0.6× 2.8k 0.7× 254 30.0k
Emil R. Unanue United States 106 24.6k 1.8× 10.3k 1.1× 3.3k 0.7× 3.5k 0.8× 1.9k 0.5× 432 39.9k
Guy A. Zimmerman United States 98 8.6k 0.6× 10.5k 1.1× 3.9k 0.9× 3.7k 0.9× 3.9k 1.0× 262 32.6k
Jack Gauldie Canada 95 9.1k 0.7× 8.2k 0.8× 3.5k 0.8× 3.3k 0.8× 1.8k 0.5× 416 31.9k
Peter M. Henson United States 118 28.1k 2.0× 16.9k 1.8× 4.0k 0.9× 4.2k 1.0× 3.4k 0.9× 375 51.4k
Volker Brinkmann Germany 91 23.2k 1.7× 19.4k 2.0× 3.6k 0.8× 5.2k 1.2× 2.4k 0.6× 250 45.3k
Marc Feldmann United Kingdom 114 23.9k 1.7× 11.3k 1.2× 3.0k 0.7× 3.5k 0.8× 3.3k 0.9× 556 53.8k
Jo Van Damme Belgium 108 16.7k 1.2× 12.7k 1.3× 2.5k 0.6× 3.0k 0.7× 4.2k 1.1× 547 41.8k
Nigel Mackman United States 106 9.9k 0.7× 12.7k 1.3× 3.4k 0.7× 3.7k 0.9× 2.0k 0.5× 508 39.6k
Warren Strober United States 114 26.2k 1.9× 11.6k 1.2× 6.6k 1.5× 8.0k 1.9× 1.6k 0.4× 437 49.5k

Countries citing papers authored by Samuel D. Wright

Since Specialization
Citations

This map shows the geographic impact of Samuel D. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel D. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel D. Wright more than expected).

Fields of papers citing papers by Samuel D. Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel D. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel D. Wright. The network helps show where Samuel D. Wright may publish in the future.

Co-authorship network of co-authors of Samuel D. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel D. Wright. A scholar is included among the top collaborators of Samuel D. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel D. Wright. Samuel D. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Parul, Anja Kipar, Udo Hetzel, et al.. (2024). Phlorotannin-Rich Ascophyllum nodosum Seaweed Extract Inhibits Influenza Infection. Viruses. 16(12). 1919–1919.
2.
Korjian, Serge, Gerald Chi, Arzu Kalaycı, et al.. (2023). Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction. European Heart Journal - Cardiovascular Pharmacotherapy. 9(4). 387–398. 15 indexed citations
3.
Kalaycı, Arzu, C. Michael Gibson, Paul M. Ridker, et al.. (2022). ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future. Current Atherosclerosis Reports. 24(7). 585–597. 22 indexed citations
4.
Gille, Andreas, Samuel D. Wright, Michael A. Tortorici, et al.. (2017). Abstract 16500: CSL112 Restores Cholesterol Efflux in Patients Immediately After Acute Myocardial Infarction. Circulation. 3 indexed citations
5.
Easton, Rachael, Andreas Gille, Denise D’Andrea, et al.. (2013). A multiple ascending dose study of CSL112, an infused formulation of ApoA‐I. The Journal of Clinical Pharmacology. 54(3). 301–310. 74 indexed citations
6.
Gille, Andreas, Denise D’Andrea, Pierluigi Tricoci, et al.. (2013). Abstract 15780: CSL112, A Novel Formulation of Human Apolipoprotein A-I, Dramatically Increases Cholesterol Efflux Capacity in Patients With Stable Atherothrombotic Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study. Circulation. 128. 3 indexed citations
7.
Gille, Andreas, Rachael Easton, Samuel D. Wright, & Charles L. Shear. (2012). Abstract 11855: CSL112, a Novel Formulation of Human Apolipoprotein A-I, Dramatically Increases Cholesterol Efflux Capacity in Healthy Subjects: A, Placebo-Controlled, Double-Blinded, Randomized Single Ascending Dose Study. Circulation. 126. 6 indexed citations
8.
Gille, Andreas, Rachael Easton, Samuel D. Wright, & Charles L. Shear. (2012). Abstract 11851: CSL112, a Novel Formulation of Human Apolipoprotein A-I, Provides Sustained Increases in Biomarkers of Cholesterol Transport Following Repeat Dosing: A Placebo-Controlled, Randomized Multiple Ascending Dose Study in Healthy Subjects. Circulation. 126. 3 indexed citations
9.
Ren, Ning, Melba Hernandez, Kang Cheng, et al.. (2009). Phenolic acids suppress adipocyte lipolysis via activation of the nicotinic acid receptor GPR109A (HM74a/PUMA-G). Journal of Lipid Research. 50(5). 908–914. 28 indexed citations
10.
Zhao, Annie, et al.. (2004). Polyunsaturated Fatty Acids Are FXR Ligands and Differentially Regulate Expression of FXR Targets. DNA and Cell Biology. 23(8). 519–526. 103 indexed citations
11.
Cai, Tian‐Quan, Qiu Guo, Birming Wong, et al.. (2002). Protein-disulfide isomerase is a component of an NBD-cholesterol monomerizing protein complex from hamster small intestine. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1581(3). 100–108. 12 indexed citations
12.
Gan, Xiaodong, John G. Menke, Karen L. MacNaul, et al.. (2001). Dual Mechanisms of ABCA1 Regulation by Geranylgeranyl Pyrophosphate. Journal of Biological Chemistry. 276(52). 48702–48708. 85 indexed citations
13.
Gan, Xiaodong, Birming Wong, Samuel D. Wright, & Tian‐Quan Cai. (2001). Production of Matrix Metalloproteinase-9 in CaCO-2 Cells in Response to Inflammatory Stimuli. Journal of Interferon & Cytokine Research. 21(2). 93–98. 60 indexed citations
14.
Sugiyama, Tsuyoshi & Samuel D. Wright. (2001). Soluble CD14 Mediates Efflux of Phospholipids from Cells. The Journal of Immunology. 166(2). 826–831. 28 indexed citations
15.
Thieringer, Rolf, et al.. (2001). 11β-Hydroxysteroid Dehydrogenase Type 1 Is Induced in Human Monocytes upon Differentiation to Macrophages. The Journal of Immunology. 167(1). 30–35. 146 indexed citations
16.
Detmers, Patricia A., Melba Hernandez, John S. Mudgett, et al.. (2000). Deficiency in Inducible Nitric Oxide Synthase Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice. The Journal of Immunology. 165(6). 3430–3435. 177 indexed citations
17.
Thieringer, Rolf, Judy Fenyk‐Melody, Patricia A. Detmers, et al.. (2000). Activation of Peroxisome Proliferator-Activated Receptor γ Does Not Inhibit IL-6 or TNF-α Responses of Macrophages to Lipopolysaccharide In Vitro or In Vivo. The Journal of Immunology. 164(2). 1046–1054. 170 indexed citations
18.
Thiéblemont, Nathalie, Rolf Thieringer, & Samuel D. Wright. (1998). Innate Immune Recognition of Bacterial Lipopolysaccharide: Dependence on Interactions with Membrane Lipids and Endocytic Movement. Immunity. 8(6). 771–777. 69 indexed citations
19.
Wright, Samuel D., et al.. (1996). Plasma Lipopolysaccharide-binding Protein Is Found Associated with a Particle Containing Apolipoprotein A-I, Phospholipid, and Factor H-related Proteins. Journal of Biological Chemistry. 271(30). 18054–18060. 82 indexed citations
20.
Wright, Samuel D., Robert Ramos, Mitesh Patel, & David S. Miller. (1992). Septin: a factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by CD14 on phagocytes.. The Journal of Experimental Medicine. 176(3). 719–727. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Niels Borregaard Breakdown of academic impact, for papers by Emil R. Unanue Breakdown of academic impact, for papers by Guy A. Zimmerman Breakdown of academic impact, for papers by Jack Gauldie Breakdown of academic impact, for papers by Peter M. Henson Breakdown of academic impact, for papers by Volker Brinkmann Breakdown of academic impact, for papers by Marc Feldmann Breakdown of academic impact, for papers by Jo Van Damme Breakdown of academic impact, for papers by Nigel Mackman Breakdown of academic impact, for papers by Warren Strober
Rankless by CCL
2026